perrhenate has been researched along with Hypoxia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azqueta, A; Cerecetto, H; Fernández, M; Giglio, J; González, M; León, A; León, E; López de Ceráin, A; Monge, A; Paolino, A; Papadopoulos, M; Pirmettis, I; Rey, A | 1 |
1 other study(ies) available for perrhenate and Hypoxia
Article | Year |
---|---|
Design and evaluation of "3 + 1" mixed ligand oxorhenium and oxotechnetium complexes bearing a nitroaromatic group with potential application in nuclear medicine oncology.
Topics: Animals; Cell Line; Cell Proliferation; China; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Gamma Cameras; Hypoxia; Ligands; Mice; Molecular Structure; Neoplasms, Experimental; Nitrobenzenes; Organometallic Compounds; Organotechnetium Compounds; Rhenium; Sensitivity and Specificity; Structure-Activity Relationship; Tissue Distribution; Xenograft Model Antitumor Assays | 2006 |